Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)

2011; Lippincott Williams & Wilkins; Volume: 25; Issue: 17 Linguagem: Inglês

10.1097/qad.0b013e32834bbaa9

ISSN

1473-5571

Autores

Babafemi Taiwo, Lu Zheng, Sébastien Gallien, Roy M. Matining, Daniel R. Kuritzkes, Cara C. Wilson, Baiba Berzins, Edward P. Acosta, Barbara Bastow, Peter Kim, Joseph J. Eron,

Tópico(s)

HIV/AIDS Research and Interventions

Resumo

To explore darunavir/ritonavir (DRV/r) plus raltegravir (RAL) combination therapy in antiretroviral-naive patients.

Referência(s)